Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03915678
Title Atezolizumab Combined With BDB001 AnD Immunogenic Radiotherapy in Patients With Advanced Solid Tumors (AGADIR)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Institut Bergonie
Indications

nasopharynx carcinoma

urinary bladder cancer

head and neck cancer

sarcoma

pancreatic cancer

triple-receptor negative breast cancer

lung non-small cell carcinoma

cervical cancer

Kaposi's sarcoma

Therapies

Atezolizumab + BDB001

Age Groups: adult | senior
Covered Countries FRA

Facility Status City State Zip Country Details
Institut Bergonié Recruiting Bordeaux 33076 France Details
Chu Brest Recruiting Brest 29200 France Details
Centre Georges François Leclerc Recruiting Dijon 21079 France Details
Centre Oscar Lambret Recruiting Lille Cedex 59020 France Details
Centre Léon Bérard Not yet recruiting Lyon Cedex 08 69373 France Details
Institut Paoli Calmettes Recruiting Marseille 13273 France Details
Institut du Cancer de Montpellier Not yet recruiting Montpellier 34298 France Details
Institut Curie Not yet recruiting Paris 75005 France Details
Institut de Cancérologie de l'Ouest - Site René Gauducheau Not yet recruiting Saint-Herblain 44805 France Details
IUCT Oncopôle Recruiting Toulouse 31052 France Details
Institut Gustave Roussy Not yet recruiting Villejuif Cedex 94805 France Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field